Form 8-K Sana Biotechnology, Inc. For: Apr 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Sana Biotechnology raises $25 million from Mayo Clinic in stock deal
April 13, 2026 4:13 PM EDTSana Biotechnology Inc. (NASDAQ: SANA) entered into a stock purchase agreement with Mayo Clinic on April 10, 2026, to sell 7.5 million shares of common stock at $3.33 per share for gross proceeds of approximately $25 million.
The transaction includes an option for Mayo Clinic to purchase an additional 7.5 million shares at the same price by... More
